Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 2252
116th Congress(2019-2020)
Empowering States to Address Drug Costs Act
Introduced
Introduced
Introduced in Senate on Jul 24, 2019
Overview
Text
Introduced in Senate 
Jul 24, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Jul 24, 2019)
Jul 24, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 2252 (Introduced-in-Senate)


116th CONGRESS
1st Session
S. 2252


To amend title XIX of the Social Security Act to expand the permitted uses of drug price information disclosed to States under the Medicaid drug rebate program.

IN THE SENATE OF THE UNITED STATES

July 24, 2019

Mr. Van Hollen (for himself and Mr. Cardin) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title XIX of the Social Security Act to expand the permitted uses of drug price information disclosed to States under the Medicaid drug rebate program.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Empowering States to Address Drug Costs Act”.

SEC. 2. Expansion of permitted uses of drug price information disclosed to States under Medicaid drug rebate program.

Clause (iv) of section 1927(b)(3)(D) of the Social Security Act (42 U.S.C. 1396r–8(b)(3)(D)) is amended to read as follows:

“(iv) to States—

“(I) to carry out this title, or

“(II) to review the information provided (including average manufacturer price, best price, and rebate calculation data) for the purposes of establishing and operating State all-payer prescription drug rate setting entities (drug affordability boards) or State multi-payer purchasing pools,”.